全文获取类型
收费全文 | 275829篇 |
免费 | 47592篇 |
国内免费 | 2218篇 |
专业分类
耳鼻咽喉 | 4205篇 |
儿科学 | 9413篇 |
妇产科学 | 5337篇 |
基础医学 | 42760篇 |
口腔科学 | 10666篇 |
临床医学 | 25323篇 |
内科学 | 64995篇 |
皮肤病学 | 12156篇 |
神经病学 | 27778篇 |
特种医学 | 7339篇 |
外国民族医学 | 18篇 |
外科学 | 36096篇 |
综合类 | 5118篇 |
现状与发展 | 4篇 |
一般理论 | 51篇 |
预防医学 | 26590篇 |
眼科学 | 6338篇 |
药学 | 21855篇 |
23篇 | |
中国医学 | 3266篇 |
肿瘤学 | 16308篇 |
出版年
2023年 | 1349篇 |
2022年 | 1934篇 |
2021年 | 5481篇 |
2020年 | 7508篇 |
2019年 | 14625篇 |
2018年 | 15597篇 |
2017年 | 14687篇 |
2016年 | 15299篇 |
2015年 | 16011篇 |
2014年 | 16802篇 |
2013年 | 19308篇 |
2012年 | 16686篇 |
2011年 | 17336篇 |
2010年 | 15579篇 |
2009年 | 10249篇 |
2008年 | 12633篇 |
2007年 | 12157篇 |
2006年 | 11896篇 |
2005年 | 11195篇 |
2004年 | 10052篇 |
2003年 | 9513篇 |
2002年 | 9097篇 |
2001年 | 6735篇 |
2000年 | 7177篇 |
1999年 | 5300篇 |
1998年 | 1270篇 |
1997年 | 954篇 |
1996年 | 833篇 |
1992年 | 2608篇 |
1991年 | 2325篇 |
1990年 | 2253篇 |
1989年 | 1893篇 |
1988年 | 1834篇 |
1987年 | 1699篇 |
1986年 | 1706篇 |
1985年 | 1600篇 |
1984年 | 1151篇 |
1983年 | 966篇 |
1979年 | 1247篇 |
1978年 | 838篇 |
1975年 | 908篇 |
1974年 | 1160篇 |
1973年 | 1211篇 |
1972年 | 1149篇 |
1971年 | 1109篇 |
1970年 | 1038篇 |
1969年 | 1119篇 |
1968年 | 1121篇 |
1967年 | 993篇 |
1966年 | 897篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
73.
Milena Soares Santos Guilherme de Sousa Ribeiro Tainara Queiroz Oliveira Renan Cardoso Nery Santos Edilane Gouveia Kátia Salgado Daniele Takahashi Cleuber Fontes Leila Carvalho Campos Mitermayer Galvão Reis Albert Icksang Ko Joice Neves Reis 《International journal of infectious diseases》2009,13(4):456-461
74.
75.
76.
77.
Jing‐Ping Zhang Limin Zheng Jiang‐Hai Wang Karl‐Eric Magnusson Xin Liu 《Phytotherapy research : PTR》2009,23(6):844-850
Ganoderma sinensis has been used widely in Oriental countries for the prevention and treatment of various diseases including cancer. Previous studies have shown that the lipid extract from Ganoderma exhibits direct cytotoxicity against tumor cells. Here, it is reported that the lipid extract from germinating G. sinensis spores, at lower concentrations that have no direct tumoricidal activity, induce potent antitumor immune responses in human monocytes/macrophages. Upon stimulation with the lipid extract, monocytes/macrophages exhibited markedly increased production of proinflammatory cytokines and surface expression of costimulatory molecules. Conditioned medium from stimulated cells effectively suppressed the growth of tumor cells. Apparently, the lipid extract triggered macrophage activation via a mechanism different from that associated with LPS. Moreover, it was observed that the lipid extract could partially re‐establish the antitumor activity of the immunosuppressive tumor‐associated macrophages. These results indicated that in addition to its direct tumoricidal activity, the lipid extract from G. sinensis spores could exert antitumor activity by stimulating the activation of human monocytes/macrophages. Copyright © 2008 John Wiley & Sons, Ltd. 相似文献
78.
Marta Méndez-López Magdalena Méndez Fernando Sánchez-Patán Isabel Casado Maria-Angeles Aller Laudino López Maria-Teresa Corcuera Maria-Jose Alonso Maria-Paz Nava Jaime Arias Jorge-Luis Arias 《Journal of gastrointestinal surgery》2007,11(2):187-194
To obtain a new model of chronic portal hypertension in the rat, two classical methods to produce portal hypertension, partial portal vein ligation and the oral administration of thioacetamide (TAA), have been combined. Male Wistar rats were divided into four groups: 1 (control; n?=?10), 2 [triple partial portal vein ligation (TPVL); n?=?9], 3 (TAA; n?=?11), and 4 (TPVL plus TAA; n?=?9). After 3 months, portal pressure, types of portosystemic collateral circulation, laboratory hepatic function tests (aspartate aminotransferase, alanine aminotransferase, bilirubin, alkaline phosphatase, and gamma-glutamyl transpeptidase) and liver histology were studied. The animals belonging to group 2 (TPVL) developed extrahepatic portosystemic collateral circulation, associated with mesenteric venous vasculopathy without hepatic destructurization or portal hypertension. Animals from group 3 (TAA) developed cirrhosis and portal hypertension but not extrahepatic portosystemic collateral circulation, or mesenteric venous vasculopathy. Finally, the animals from group 4 (TPVL?+?TAA) developed cirrhosis, portal hypertension, portosystemic collateral circulation, and mesenteric venous vasculopathy. The association of TPVL and TAA can be used to obtain a model of chronic portal hypertension in the rat that includes all the alterations that patients with hepatic cirrhosis usually have. This could, therefore, prove to be a useful tool to study the pathophysiological mechanisms involved in these alterations. 相似文献
79.
80.